Key result
Primary PCI hospitalizations rose alongside a ~122% increase in population-adjusted in-hospital mortality in Brazil.
Why the study?
Implementation, utilization patterns, costs, and outcomes of primary percutaneous coronary intervention for acute myocardial infarction across Brazil's diverse regions remained poorly characterized.
Observational
Absolute Event Rate: 0.51% vs 0.23%
Despite a 190% increase in pPCI utilization and decreased inflation-adjusted costs in Brazil's public health system from 2008 to 2023, population-adjusted in-hospital mortality rose, highlighting persistent regional disparities and systemic challenges in timely care delivery.
Rising MI hospitalizations, mortality, and costs with widening regional disparities signal urgent access gaps; leaves open effective policy interventions.
BACKGROUND: Primary percutaneous coronary intervention (pPCI) is the gold standard treatment for acute myocardial infarction (MI). Yet, its implementation across Brazil's diverse regions remains poorly characterized. Although Brazil's public healthcare system (Sistema Único de Saúde [SUS]) serves approximately 72% of Brazil's population, comprehensive analysis of pPCI utilization patterns and outcomes has been limited. This study aimed to evaluate contemporary trends in pPCI utilization, associated costs, and clinical outcomes across Brazil's regions from 2008 to 2023. METHODS: We conducted a retrospective observational study of emergency MI hospitalizations treated with pPCI using Brazil's Unified Health System databases. Population‑adjusted rates of pPCI, inflation‑adjusted standardized costs, in‑hospital mortality, and densities of registered pPCI‑capable facilities were estimated for Brazil and its five regions. Five‑year interval means and cumulative changes were computed. Statistical significance was evaluated with Z‑tests and 95% confidence intervals. RESULTS: National pPCI hospitalizations increased by 190.94%, with marked regional variation. The South reached 26.22 procedures per 100,000 population in 2023, while the North remained critically low (1.49 per 100,000). After inflation adjustment, standardized costs declined nationally (-36.34% per day; -47.12% per hospitalization), yet population‑adjusted in‑hospital mortality rose by 121.74% over the study period. Across regions, most pPCI‑capable facilities were private rather than public or philanthropic. Disparities were most pronounced between the South and North regions, reflecting broader socioeconomic inequities. CONCLUSION: Brazil has substantially increased pPCI utilization, but persistent regional disparities and rising population‑adjusted mortality highlight systemic challenges in timely, high‑quality care. Targeted interventions - standardized protocols, strengthened infrastructure and transfer networks in underserved areas, and focused investment - are needed to improve equity and cardiovascular outcomes nationwide.
No takes yet. Share an insight, caveat, or question.
Arzumanov et al. (2026) conducted an observational in Emergency myocardial infarction. Primary percutaneous coronary intervention (pPCI) vs. Historical baseline (2008) was evaluated on Population-adjusted in-hospital mortality (deaths per 100,000 population). Despite a 190.94% increase in primary percutaneous coronary intervention hospitalizations and declining standardized costs, population-adjusted in-hospital mortality rose by 121.74% in Brazil from 2008 to 2023.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: